申聯生物(688098.SH):擬將上海口蹄疫合成肽疫苗生產線搬遷至蘭州分公司
格隆匯2月10日丨申聯生物(688098.SH)公佈,公司擬將位於上海工廠的口蹄疫合成肽疫苗生產線搬遷至蘭州分公司,目前上海工廠口蹄疫合成肽疫苗生產線已停產,預計停產時間一年,具體停產時間取決於蘭州分公司何時建成口蹄疫合成肽疫苗生產線。待蘭州分公司口蹄疫合成肽疫苗生產線建成後,將以蘭州分公司的名義重新申請相關資質後恢復生產。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.